| Market Cap | 59.19K | P/E | 0.10 | EPS this Y | - | Ern Qtrly Grth | - |
| Income | 402.84k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | 29.05M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 62.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -93.00% |
| Recommedations | - | Quick Ratio | 1.10 | Shares Outstanding | 59.19M | 52W Low Chg | 900.00% |
| Insider Own | 43.99% | ROA | 1.10% | Shares Float | 28.96M | Beta | -0.68 |
| Inst Own | - | ROE | 0.85% | Shares Shorted/Prior | -/- | Price | 0.00100 |
| Gross Margin | 0.56% | Profit Margin | 1.39% | Avg. Volume | - | Target Price | - |
| Oper. Margin | -1,415.24% | Earnings Date | - | Volume | 2,500 | Change | 0.00% |
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China and the United States. It offers traditional Chinese medicine (TCM) raw materials in the form of yew tree branches and leaves to manufacture TCM containing taxol. The company is also involved in processing and selling yew raw materials used in the manufacture of traditional Chinese medicine; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber; selling agricultural products, such as yew candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps; and selling wood ear mushroom. In addition, it engages in the marketing and sale of cosmetics. The company was incorporated in 2007 and is based in El Monte, California.
